| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 421.63B | 452.46B | 421.85B | 369.10B | 352.06B |
| Gross Profit | 105.16B | 113.36B | 105.41B | 86.19B | 90.12B |
| EBITDA | 34.43B | 33.61B | 32.89B | 14.73B | 18.47B |
| Net Income | 21.51B | 12.48B | 25.65B | -2.80B | 2.07B |
Balance Sheet | |||||
| Total Assets | 445.21B | 410.96B | 423.40B | 390.43B | 369.17B |
| Cash, Cash Equivalents and Short-Term Investments | 35.90B | 36.87B | 35.04B | 37.75B | 36.69B |
| Total Debt | 94.02B | 103.00B | 118.43B | 128.65B | 100.83B |
| Total Liabilities | 264.79B | 265.22B | 282.08B | 291.14B | 261.53B |
| Stockholders Equity | 180.33B | 145.67B | 141.25B | 99.21B | 107.58B |
Cash Flow | |||||
| Free Cash Flow | 12.36B | 28.76B | 12.53B | -13.64B | -10.89B |
| Operating Cash Flow | 20.65B | 39.26B | 24.72B | -3.15B | 5.92B |
| Investing Cash Flow | -10.28B | -19.63B | -14.34B | -17.62B | -17.60B |
| Financing Cash Flow | -11.87B | -17.86B | -15.71B | 23.27B | 1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥71.45B | 14.24 | 8.37% | 3.06% | 5.57% | -28.91% | |
68 Neutral | ¥257.12B | 10.38 | 12.24% | 2.31% | -6.81% | 72.30% | |
68 Neutral | ¥28.88B | 6.45 | 14.95% | 0.77% | 1.57% | -2.93% | |
68 Neutral | ¥42.90B | 17.96 | ― | 4.43% | -0.53% | -31.86% | |
67 Neutral | ¥43.35B | 15.92 | ― | 2.93% | -1.36% | -9.69% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥4.17B | 11.96 | ― | 2.01% | 2.87% | 60.30% |